Advertisement

Topics

NousCom's Neoantigen-based Vaccine Synergizes With NKTR-214 to Cure Established Tumors in ...

03:00 EST 13 Nov 2017 | BioMedReports - Blog

NousCom combined its vectored genetic vaccine encoding multiple cancer neoantigens, capable of inducing potent and broad T cell responses, with NKTR-214, designed to expand the

Read more...

Original Article: NousCom's Neoantigen-based Vaccine Synergizes With NKTR-214 to Cure Established Tumors in ...

NEXT ARTICLE

More From BioPortfolio on "NousCom's Neoantigen-based Vaccine Synergizes With NKTR-214 to Cure Established Tumors in ..."

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Vaccine
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one ...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...